Optogenetics Restores Partial Vision in Half of Retinitis Pigmentosa Patients in Early Trial
Source Summary
A small clinical trial demonstrated that optogenetics, a technique using light-sensitive proteins, restored photosensitivity in approximately half of patients with retinitis pigmentosa, a progressive eye disease causing vision loss. The results indicate the potential of optogenetics as a treatment approach for this currently incurable condition.
Why it matters
Retinitis pigmentosa is a progressive, currently incurable genetic eye disease; partial restoration of light sensitivity in half of trial participants represents a significant early-stage advance in treating vision loss from this condition.
